Beactica AB


UPPSALA, Sweden, December 6, 2011 - Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Almac Discovery Ltd., an independent member of the Almac Group Ltd.

UPPSALA, Sweden, April 27, 2011 - Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Janssen Research & Development, a division of Janssen Pharmaceutica NV.

UPPSALA, Sweden - Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc.
Older News
S M T W T F S
20 21 22 23 24 25 26
27 28 29 30 1 2 3
4 5 6 7 8 9 10
Copyright© 2011 The Gaea Times